SCHEMBL7413882

SCHEMBL7413882

CCc1[nH]c(=O)oc1-c1ccnc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 8/20 0.47
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
TGFBR1 P36897 2/20 0.43
BMPR1B O00238 1/20 0.43
RAF1 P04049 1/20 0.43
BRAF P15056 1/20 0.43
BMPR1A P36894 1/20 0.43
ACVR1B P36896 1/20 0.43
ACVRL1 P37023 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
IDO1 P14902 1/20 0.42
TP53 P04637 2/20 0.41
MAPT P10636 2/20 0.41
PTK2B Q14289 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415425 0.90 ELANE (0.44) ACVR1NPC1RAB9ATGFBR1BMPR1B
SCHEMBL9365338 0.87 PARP1 (0.43) ACVR1NPC1RAB9ATGFBR1BMPR1B
SCHEMBL9360266 0.81 ACVR1 (0.43) ACVR1IDO1MAPTELANECYP1A2
SCHEMBL7276535 0.74 LMNA (0.43) NPC1RAB9AKDM4EALDH1A1HPGD
SCHEMBL9360294 0.70 NPC1 (0.49) NPC1RAB9ATGFBR1KDM4EALDH1A1
SCHEMBL9360263 0.69 NPC1 (0.47) ACVR1NPC1RAB9ATGFBR1BMPR1B
SCHEMBL805503 0.69 LOXL2 (0.64) NPC1RAB9AKDM4EALDH1A1TP53
SCHEMBL9360720 0.68 PARP1 (0.39) ALDH1A1AURKB
SCHEMBL29699887 0.68 CYP1A2 (0.60) NPC1RAB9ATGFBR1KDM4EALDH1A1
SCHEMBL1227713 0.68 CYP1A2 (0.60) NPC1RAB9ATGFBR1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5610171-A Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones MERRELL PHARMACEUTICALS INC. (US) 1997-03-11 US disclosed
EP-0428105-B1 Use of quinolyl- and isoquinolyloxazole-2-ones for the production of a medicament for the prevention of glycoprotein enveloped virus infectivity MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
EP-0428107-B1 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
EP-0539575-A1 INHIBITION OF METASTASIS IN PATIENTS HAVING CANCER WITH PYRIDYLOXAZOLE-2-ONES. MERRELL DOW PHARMA (US) 1993-05-05 EP disclosed
WO-1992020337-A2 INHIBITION OF METASTASIS IN PATIENTS HAVING CANCER WITH PYRIDYLOXAZOLE-2-ONES MERRELL DOW PHARMACEUTICALS INC. (US) 1992-11-26 WO disclosed